Company Filing History:
Years Active: 2000
Title: Catherine Jessus: Innovator in Cancer Research
Introduction
Catherine Jessus is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer research, particularly through her innovative work on protein interactions that play a crucial role in cellular processes.
Latest Patents
Catherine Jessus holds a patent titled "Interactions between RaF proto-oncogenes and CDC25 phosphatases." This invention stems from her discovery that CDC25 phosphatases and Raf proteins can physically interact to form protein-protein complexes. The Raf protein mediates the activation of CDC25 phosphatases. Her patent provides both cell-free and cellular assays for detecting agents that modulate the ras-dependent activation of CDC25. This includes methods that affect the binding of a CDC25 protein with Raf or Raf-associated complexes. Additionally, the patent discloses a method for transforming and immortalizing cells, particularly primary cell cultures.
Career Highlights
Catherine Jessus has had a distinguished career, working at Cold Spring Harbor Laboratory, where she has been involved in groundbreaking research. Her work has not only advanced scientific understanding but has also opened new avenues for therapeutic interventions in cancer treatment.
Collaborations
Throughout her career, Catherine has collaborated with notable scientists, including David H. Beach and Konstantin Galaktionov. These collaborations have enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Catherine Jessus is a trailblazer in cancer research, with her innovative patent highlighting the critical interactions between proteins that influence cell behavior. Her contributions continue to impact the scientific community and pave the way for future discoveries.